好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Gender Gap in Movement Disorders Research: A Decade of Uneven Progress in Academic Authorship
Movement Disorders
P10 - Poster Session 10 (8:00 AM-9:00 AM)
16-003

To evaluate gender representation in authorship and leadership positions within movement disorders publications over the past decade.

Women remain underrepresented in academic medicine, particularly in leadership roles. In neurology overall, women comprise 39% of authors and 29% of senior authors, yet no focused analysis has been conducted within the movement disorders field. Understanding trends in gender authorship can inform initiatives to improve equity and mentorship.

A cross-sectional meta-analysis was conducted following PRISMA guidelines. Four reviewers analyzed all movement disorder–related articles published in 20 high-impact neurology journals (impact factor 6.6–45.5) and two flagship movement disorders journals between January-December 2024, compared with 2014. Author gender was identified using the Genderize database. We evaluated the proportion of female first, second, and senior authors and correlated representation with journal impact factors and editorial leadership.

We identified 1,421 movement disorder articles (901 from 2024;507 from 2014) encompassing 14,953 authors. Women were more likely to publish reviews and brief reports than large clinical studies/research. Overall, women represented 41% of authors in 2024, compared to 40% in 2014. Female first authorship declined from 62% to 42%, and senior authorship from 38% to 25%.

The percentages for first and senior female authors varied significantly by journal (first:14%-63%,senior:14%-44%.).We observed an inverse correlation between female authorship and the journals' impact factors.

Overall the representation was lowest in Lancet Neurology-(35%) where no senior female authors for research articles were identified in 2024.In Neurology women represented 25% of senior authors.

Only 36% of journals had female Editors-in-Chief (2024).Women were more likely to publish reviews and brief reports than large clinical studies/research.

 

Despite progress, gender disparity persists in movement disorders research. Women remain markedly underrepresented in senior authorship roles—positions that signify mentorship and leadership.Targeted initiatives to promote mentorship, leadership training, and equitable publishing opportunities are urgently needed to close the authorship leadership gap.

Authors/Disclosures
Diana Angelika Olszewska, MD, PhD (Cork University Hospital)
PRESENTER
Dr. Olszewska has nothing to disclose.
Divyani Garg, MD, FRCP (All India Institute of Medical Sciences, New Delhi) Dr. Garg has nothing to disclose.
Zakiyah F. Aldaajani, MD Dr. Aldaajani has nothing to disclose.
Manon Auffret, PhD, PharmD, DAAN Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aguettant. The institution of Dr. Auffret has received research support from Oxylis Medical. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Tamine Capato, PhD, PT Dr. Capato has nothing to disclose.
Marina Picillo, MD (AOU San Giovanni Di Dio E Ruggi D'Aragona, Centro Parkinson) Dr. Picillo has nothing to disclose.
Claudia Trenkwalder, MD (Center For Parkinsonism and Movement Disorders) Dr. Trenkwalder has received personal compensation for serving as an employee of Paracelsus-Kliniken. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esteve. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer. Dr. Trenkwalder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Trenkwalder has received research support from DLR /BMBF. Dr. Trenkwalder has received intellectual property interests from a discovery or technology relating to health care.
Leila Ali, Jr., MD Dr. Ali has nothing to disclose.
Melissa Armstrong, MD, MSc, FAAN, FAAN (UF Department of Neurology) The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Michiko K. Bruno, MD, FAAN (Queens Medical Center) The institution of Dr. Bruno has received research support from Michael J. Fox Foundation . The institution of Dr. Bruno has received research support from PIKO. The institution of Dr. Bruno has received research support from CurePSP. The institution of Dr. Bruno has received research support from Parkinson's Foundation .
Veronica A. Bruno, MD (University of Calgary Foothills) Dr. Bruno has nothing to disclose.
Eiko N. Minakawa, MD, PhD The institution of Dr. Minakawa has received research support from The Japan Society for the Promotion of Science (JSPS). The institution of Dr. Minakawa has received research support from Japan Agency for Medical Research and Development (AMED). The institution of Dr. Minakawa has received research support from Japan Science and Technology Agency (JST).
Walaa Elsayed Walaa Elsayed has nothing to disclose.
Susan Fox, MD, FAAN (Toronto Western Hospital) The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.